HOMOLOGOUS RECOMBINANT REPAIR PATHWAY GENE MUTATIONS AND RELATED CANCERS IN UAE

This data was collected from patients at a single tertiary hospital who were tested for Homologous Recombinant Repair pathway genes, including BRCA1/2, and HR pathway defects. This data also includes the demographics of the patients, along with other variables such as family history, second primary cancers, hormone status (ER/PR), HER2 status, surgical treatments, lines of treatments, PARP inhibitor utilization, and response.